Clinical Trials Browser

Prostatic Neoplasms

NCT07468708 2026-04-17

The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer

Phase EARLY_PHASE1 Recruiting

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT06645808 2025-12-29

VARTUTRACE

Phase EARLY_PHASE1 Recruiting

32 enrolled

BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms

NCT06516510 2025-09-25

A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer

Phase EARLY_PHASE1 Terminated

17 enrolled

Genitourinary

Prostatic Neoplasms

NCT04726033 2024-05-01

CUPID

Phase EARLY_PHASE1 Completed

14 enrolled

Genitourinary

Prostatic Neoplasms

NCT05773703 2023-12-13

Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer

Phase EARLY_PHASE1 Completed

23 enrolled

Genitourinary

Prostatic Neoplasms

NCT05725070 2023-10-06

Phase 0/1 Study of 212Pb-NG001 in mCRPC

Phase EARLY_PHASE1 Completed

3 enrolled

Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT04116164 2023-09-25

Safety and Targeting of Anti-hk2 Antibody in mCRPC

Phase EARLY_PHASE1 Terminated

27 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant

NCT01253213 2023-08-01

BR55 in Prostate Cancer: an Exploratory Clinical Trial

Phase EARLY_PHASE1 Completed

26 enrolled

Genitourinary

Prostatic Neoplasms

NCT05961111 2023-07-27

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

20 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Sarcoma

NCT02826382 2023-01-12

Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041

Phase EARLY_PHASE1 Completed

14 enrolled

Genitourinary

Prostatic Neoplasms

NCT05395260 2022-08-19

FL- 101 Study in Non-Metastatic MIBC

Phase EARLY_PHASE1 Withdrawn

Genitourinary

Urinary Bladder Neoplasms

NCT03692663 2022-08-01

Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer

Phase EARLY_PHASE1 Unknown

9 enrolled

Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT03454243 2019-04-25

TITAN

Phase EARLY_PHASE1 Terminated

1 enrolled

DermatologicGenitourinaryLymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Hodgkin Disease, Melanoma

NCT00884520 2010-03-16

VM4-037

Phase EARLY_PHASE1 Completed

16 enrolled

GastrointestinalGenitourinaryHead & NeckThoracic

Hypoxia, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms

Clinical Trials

The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer

The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer

VARTUTRACE

A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer

CUPID

Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer

Phase 0/1 Study of 212Pb-NG001 in mCRPC

Safety and Targeting of Anti-hk2 Antibody in mCRPC

BR55 in Prostate Cancer: an Exploratory Clinical Trial

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041

FL- 101 Study in Non-Metastatic MIBC

Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer

TITAN

VM4-037